Veracyte, Inc. (VCYT)
44.65
-3.02
(-6.34%)
USD |
NASDAQ |
Oct 06, 16:00
44.41
-0.24
(-0.54%)
After-Hours: 06:31
Veracyte Gross Profit Margin (Quarterly) : 71.93% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 71.93% |
| March 31, 2026 | 72.32% |
| December 31, 2025 | 72.07% |
| September 30, 2025 | 67.76% |
| June 30, 2025 | 67.42% |
| March 31, 2025 | 67.61% |
| December 31, 2024 | 64.47% |
| September 30, 2024 | 66.19% |
| June 30, 2024 | 66.23% |
| March 31, 2024 | 62.50% |
| December 31, 2023 | 64.31% |
| September 30, 2023 | 61.86% |
| June 30, 2023 | 60.08% |
| March 31, 2023 | 60.65% |
| December 31, 2022 | 59.16% |
| September 30, 2022 | 57.81% |
| June 30, 2022 | 57.35% |
| March 31, 2022 | 55.99% |
| December 31, 2021 | 57.22% |
| September 30, 2021 | 54.63% |
| June 30, 2021 | 60.65% |
| March 31, 2021 | 60.05% |
| December 31, 2020 | 62.57% |
| September 30, 2020 | 61.16% |
| June 30, 2020 | 54.85% |
| Date | Value |
|---|---|
| March 31, 2020 | 55.13% |
| December 31, 2019 | 62.46% |
| September 30, 2019 | 68.30% |
| June 30, 2019 | 68.71% |
| March 31, 2019 | 68.82% |
| December 31, 2018 | 63.34% |
| September 30, 2018 | 61.36% |
| June 30, 2018 | 60.25% |
| March 31, 2018 | 56.85% |
| December 31, 2017 | 56.33% |
| September 30, 2017 | 57.55% |
| June 30, 2017 | 57.79% |
| March 31, 2017 | 56.90% |
| December 31, 2016 | 62.85% |
| September 30, 2016 | 64.34% |
| June 30, 2016 | 55.24% |
| March 31, 2016 | 51.69% |
| December 31, 2015 | 54.12% |
| September 30, 2015 | 52.30% |
| June 30, 2015 | 54.60% |
| March 31, 2015 | 59.30% |
| December 31, 2014 | 60.12% |
| September 30, 2014 | 57.63% |
| June 30, 2014 | 54.29% |
| March 31, 2014 | 51.75% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 96.13% |
| Quantum Cyber NV | -- |
| bioAffinity Technologies, Inc. | 23.91% |
| Recursion Pharmaceuticals, Inc. | -202.4% |
| Karyopharm Therapeutics, Inc. | 96.75% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 8.78% |
| Return on Assets | 8.09% |
| Return on Invested Capital | 8.50% |
| Profit Margin (Quarterly) | 16.96% |
| Operating Margin (Quarterly) | 15.89% |
| Return on Net Operating Assets | 11.60% |